US biopharma Syntis Bio, which is developing oral therapies for obesity, diabetes and rare diseases, has announced the close ...

Swiss biopharma company BioVersys (today announced a research and exclusive license option agreement with the Japanese ...

A clinical-stage biotech company based in Los Altos, California, developing treatments for kidney diseases.

Australian neurodegenerative diseases specialist Neurizon Therapeutics has agreed an exclusive global license agreement with ...

A federal judge has blocked the US Department of Health and Human Services from moving forward with a major workforce ...

Artificial Intelligence (AI) is reshaping pharmacovigilance, promising faster detection of safety signals hidden within ...

Alnylam Pharmaceuticals (Nasdaq: ALNY) has won European Commission approval for Amvuttra (vutrisiran) to treat transthyretin ...

Under the terms of the deal, HanchorBio will receive an upfront payment of $10 million, with additional payments tied to ...

US biotech Jazz Pharmaceuticals yesterday announced that the European Commission (EC) has granted conditional marketing ...

US pharma giant Merck & Co today revealed that the US Food and Drug Administration (FDA) has accepted and granted priority ...

California biotech Unnatural Products (UNP) announced a strategic multi-target research collaboration with Dutch immunology ...

US biotech IGM Biosciences yesterday revealed it has entered into a definitive merger agreement to be acquired by Concentra ...